Tumor-derived CCL5 does not contribute to breast cancer progression.
about
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerTumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in FibroblastsA novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.CCL5 as an adjuvant for cancer immunotherapy.CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.CC chemokine receptor 5: the interface of host immunity and cancerThe potential to target CCL5/CCR5 in breast cancer.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
P2860
Q26784324-A4E836A3-72EF-45B6-A711-1A6DB1F1CB7AQ34503208-5CF29A66-534D-4D36-87FD-3EF47CBDA12FQ35166851-C5054934-4CB7-4994-9D19-5BC4C911AF51Q36594706-C2691636-35B7-4104-91F4-F8C7C023DEB6Q36655043-873DD0E7-49D4-407B-B040-2EF992A576F1Q37269350-8E26071E-4880-4879-962C-549B9CA2DC1EQ37710085-081619A1-A899-42E6-A6A6-3645A7038718Q37729639-96E92E4D-A00F-49A7-A905-7D9A0DC7BE0BQ38193064-C54AE3B9-5934-4358-9440-7F9508EB7717Q38254356-54A0421E-F249-4A1A-BD26-CF26F8AAAEB3Q38998423-D3232A84-0D7A-479C-8104-1B75E9B3FCB8
P2860
Tumor-derived CCL5 does not contribute to breast cancer progression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
type
label
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
prefLabel
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
P2093
P2860
P1476
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
P2093
Cara M O'Donnell
Jacqueline M Golden
Mevan M Jayasinghe
Michael T Werner
Priyanka Nair
Robert A Kurt
P2860
P2888
P304
P356
10.1007/S10549-007-9802-6
P407
P577
2007-11-03T00:00:00Z
P6179
1022743288